Search results
Author(s):
Hisham Dokainish
Added:
6 years ago
INTERCHF - Global Variations in Mortality Among Heart Failure Patients.
Interview with Professor Hisham Dokainish from McMaster University, Hamilton, CA at HFA 2017.
View more
Author(s):
Benedikt Schrage
Added:
2 years ago
In this short video, Dr Benedikt Schrage (University Heart and Vascular Center Hamburg, DE) summarises the main findings from the analysis that looked into the association between AID/FID with incident CV disease and mortality in 2 164 individuals from three European population-based cohorts. The study, published in the ESC Heart Failure (2021), found that attributable risks ofFID for the tested…
View more
Author(s):
Ambarish Pandey
Added:
6 years ago
Ambarish Pandey discusses the GWTG-HF Registry -30-Day Risk Standardized Mortality and Long-Term Survival After HF Hospitalization
Filmed by Radcliffe Cardiology on-site at theACC 2018 congress in Orlando, US
View more
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Stephen J Greene
,
et al
Added:
3 years ago
Hospitalisation is a critical event in the clinical course of heart failure (HF) and despite relatively rapid relief of symptoms, hospitalisation is followed by an increased risk of death and re-hospitalisation.1 While performance measures have been developed in the last few years with the intent of improving post-discharge outcomes, post-discharge mortality rates remain unchanged or have…
View more
HFA 2017: Targeting Heart Rate to Improve Mortality in Heart Failure With Reduced Ejection Fraction
Author(s):
John GF Cleland
Added:
6 years ago
Video
Author(s):
Javed Butler
,
Stefan Anker
Added:
5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker
Filmed on-site at ESC 2018 by Radcliffe Cardiology.
View more
Author(s):
Uwe Zeymer
Added:
4 months ago
AHA 23 - We are joined on-site by Prof Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, DE) to discuss the findings from a sub-analysis of the ECLS-SHOCK trial.This sub-analysis investigates the impact of cardiac arrest before randomisation on the efficacy of ECLS in patients with infarct-related cardiogenic shock. Investigators enrolled 420 patients with acute MI and cardiogenic shock across 41…
View more
De Novo HF Versus ADCHF
Author(s):
Wilson Matthew Raffaello
,
Joshua Henrina
,
Ian Huang
,
et al
Added:
3 years ago
Article
The Burden of Disease of HFpEF
Author(s):
Chris J Kapelios
,
Bahira Shahim
,
Lars H Lund
,
et al
Added:
4 months ago
Article
Author(s):
Nicholas Wettersten
,
Alan S Maisel
Added:
3 years ago
Cardiac troponin (cTn) is the core biomarker for the diagnosis of a myocardial infarct (MI).1 Indeed, as stated in Table 1, it meets all the definitions of a biomarker for acute coronary syndrome (ACS), as suggested by Maisel.2 In the setting of ACS, in addition to its diagnostic use, it is prognostic, clinically actionable and can be monitored during therapy as a surrogate of improvement. In…
View more